This cohort study evaluates neurodevelopmental outcomes among infants exposed in utero to antiretroviral therapy consisting of integrase strand inhibitor–based regimens compared with protease inhibitor– or nonnucleoside reverse transcriptase inhibitor–based regimens.
Source link